OLIPASS Corporation (KOSDAQ: A244460)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
OLIPASS Corporation (KOSDAQ: A244460) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.72M.
trading between 1.57K and 9.25K.
Tweenvest scores OLIPASS Corporation across four factors: quality 34/100, value 61/100, growth 100/100. Its strongest factor is growth.
A244460 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.72M
- Revenue (TTM)
- $3.90M
- P/E
- —
- EPS
- -5,043.35
- Dividend yield
- —
- Beta (5Y)
- -0.34
- 52-week high
- ₩9,250.00
- 52-week low
- ₩1,568.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.09M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Acurx Pharmaceuticals, Inc.NasdaqCM: ACXP | $5.98M | $1.14 | -0.44% |
| Niki BioSolutions, Inc.NasdaqCM: NIKI | $5.97M | $2.03 | -49.25% |
| Can-Fite BioPharma Ltd.TASE: CANF | $5.94M | ₪3.04 | -3.00% |
| Cizzle Biotechnology Holdings PlcLSE: CIZ | $5.81M | £0.01 | -29.31% |
| Imunon, Inc.NasdaqCM: IMNN | $5.72M | $1.02 | -5.56% |
| AquaBounty Technologies, Inc.NasdaqCM: AQB | $5.71M | $1.11 | +8.82% |
| NeuroSense Therapeutics Ltd.NasdaqCM: NRSN | $5.68M | $3.07 | -16.12% |
| Quantum Genomics Société AnonymeENXTPA: ALQGC | $5.65M | €0.07 | -0.28% |
Figures last refreshed Oct 18, 2026.